The European Union has officially approved the use of two types of antibody treatment for COVID-19, 'Leklora' developed by Celltrion and 'Lonapreve' of US pharmaceutical company Regeneron.
The European Medicines Agency said on its website on the 12th local time, "Rekkona and Lonapreve have been officially approved in the EU" and "This is in accordance with the EU Commission's approval of the sale of these two products."
With this, Lekkorna became the first domestic antibody drug to obtain EU approval.